D. Wesche
Clinical Pharmacokinetics · 2010
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from D. Wesche's perspective
Ordered by how strongly the researchers D. Wesche trusts endorse each paper. Same corpus, a different order for every researcher.
- The mechanisms of action of gabapentin and pregabalin. (Current opinion in pharmacology (Print))
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial (The Lancet)
- A high resolution HLA and SNP haplotype map for disease association studies in the extended human MHC (Nature Genetics)
- Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. (The Lancet)
- Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? (British Journal of Dermatology)
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin (Nature Genetics)
- MaCH: Using Sequence and Genotype Data to Estimate Haplotypes and Unobserved Genotypes (Genetic Epidemiology)
- Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. (The Lancet)
- Pregabalin for the treatment of postherpetic neuralgia (Neurology)
- The anatomy of memory: an interactive overview of the parahippocampal–hippocampal network
Their papers
- A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin (2010) — 625 citations